Home » Topics » BioWorld Science

BioWorld Science
RSS

Nine-month results from TAXUS VI study

May 28, 2004

Progress of dopamine D1-selective antagonist lines up milestones for CeNeS

May 28, 2004

European orphan drug status for HuMax-CD4 in CTCL

May 28, 2004

R&D projects proceeding as planned at Actelion

May 28, 2004

Novartis reports Q1 regulatory and clinical highlights

May 28, 2004

Renzapride improves bowel function and reduces abdominal pain/discomfort in IBS

May 28, 2004

BPC-157 reported to promote ulcer healing in rats

May 28, 2004

Visilizumab found effective in refractory ulcerative colitis

May 28, 2004

MR tacrolimus can replace standard tacrolimus in liver transplantation

May 28, 2004

LEA-29Y superior to ciclosporin in renal transplantation

May 28, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...